Cancer

Cancer stands as the second leading cause of mortality in the United States. Among women, breast cancer holds the foremost position, while among men, prostate cancer, second only to lung cancer, accounts for the highest cancer-related deaths. Ongoing research underscores the multifaceted anti-cancer properties of Vitamin E Tocotrienols:

  1. They act as potent antioxidants and anti-inflammatory agents, neutralizing harmful Free Radicals.

  2. They enhance programmed cell death (Apoptosis) in cancer cells through the stimulation of Caspase-3 pathways.

  3. They inhibit NF-Kappa B, a pivotal pro-inflammatory protein that fosters cancer development.

  4. They induce Apoptosis, prompting self-destruction of cancer cells.

  5. They impede VEGF (Vascular Endothelial Growth Factor), hampering the formation of new blood vessels crucial for cancer nourishment.

  6. They hinder the enzyme responsible for excessive cholesterol production in cancer cells, effectively starving the growing cancer.

Recent studies have unveiled no less than 33 distinct cancer-preventive activities exhibited by Vitamin E Gamma and Delta Tocotrienols. Notably, in the comprehensive "Vitamin E and Cancer Prevention" study spanning 40 pages in the Journal of Molecular Carcinogenesis (2020) by Professor M. Malafa and colleagues, funded by the National Cancer Institute.

Annatto Tocotrienols have demonstrated consistent anti-tumor benefits, impediment of cancer cell proliferation, suppression of metastasis (spread), and enhanced efficacy of chemotherapy drugs, particularly in combating resistant and recurrent cancers. These findings are elucidated in the 18-page research paper titled "Molecular Mechanisms of Action of Tocotrienols in Cancer," published in the International Journal of Molecular Sciences (2019).

References

General Cancer

Breast Cancer

Colon Cancer

Lung Cancer

Ovarian Cancer

Pancreatic Cancer

Prostate Cancer